PROVE-IT to IMPROVE-IT Why LDL-C Goals Still Matter in Post-ACS Patients

R. Scott Wright, Joseph Murphy

Research output: Contribution to journalEditorialpeer-review

2 Scopus citations
Original languageEnglish (US)
Pages (from-to)362-364
Number of pages3
JournalJournal of the American College of Cardiology
Issue number4
StatePublished - Feb 2 2016


  • acute coronary syndrome
  • ezetimibe
  • lipid modifying therapy
  • secondary prevention

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this